Acute and Chronic Therapeutic Impact of a Vasopressin 2 Antagonist (Tolvaptan) in Congestive Heart Failure - ACTIV in CHF

Description:

The goal of the trial was to evaluate the acute and chronic effects of treatment with the vasopressin 2 antagonist tolvaptan compared with placebo in patients with congestive heart failure (CHF).